Last fall, we asked the question on our other blogWill Invokana Injury Cases Be Centralized? At that time, a growing number of injured patients had filed lawsuits in Federal Courts. Our firm has been investigating potential Invokana injury claims for some time. For background information on the drug Invokana and its associated injuries, you can read more on the Hot Topics section of our law firm website.

Continue Reading

IMG-31516

At the Blackwell Law Firm website we have a section called Hot Topics. That section provides news and research related to current legal issues. Many of these issues involve injury from bad drugs or dangerous medical devices. Among those topics — two hernia mesh products. These are Ethicon’s Physiomesh and Atrium’s C-Qur mesh. We are currently investigating injuries by Alabama patients which may be associated with these two products.


Continue Reading

Hernia Repair Surgeries Are Common

Hernia repair surgeries are among the most common surgeries in the United States. More than a million of these surgeries are performed each year in this country. Hernia repair surgeries can be performed with or without the implantation of mesh. As with mesh used in some other repair surgeries, the question becomes – do the benefits of using hernia mesh for the patient outweigh the risks?


Continue Reading

The article in The Hill begins:

The nation’s leading business group is mounting a new attack on advertisements run by trial lawyers that tell consumers about the negative side effects from medical drugs and devices.

Let me start — I don’t like modern attorney advertising. Locally in northern Alabama, we have an attorney on television advertising for automobile accident injury cases who refuses to help injured people in court. And, we have outside lawyers running ads for drug cases who are not even licensed in Alabama.


Continue Reading

I have not discussed Federal court diversity jurisdiction in a long time. Yet, the issue is important for attorneys handling significant injury claims.

A SHORT DEFINITION OF FEDERAL COURT DIVERSITY JURISDICTION

Federal courts are courts of limited jurisdiction. Generally, Federal courts have jurisdiction of claims under the U.S. Constitution, treaties and Federal statutes.

In September, I discussed new anticoagulants Xarelto and Eliquis. My prior post concludes by noting patients deserve drugs approved only after careful study for safety.

Shortly after that post, the ISMP Quarterwatch also raised issues concerning the safety of new anticoagulants rivaroxaban (Xarelto), dabigatron (Pradaxa), and apixaban (Eliquis). According to Quarterwatch:

The adverse event

Will Eliquis join Pradaxa and Xarelto as another anti-coagulant drug facing claims of severe internal bleeding? Pradaxa was the first of these three new anti-coagulants (blood thinners). It hit the market in 2010. Sales quickly boomed. However, adverse reports of severe internal hemorrhaging and bleeding soon followed. In May 2014, Pradaxa’s manufacturer settled about 4,000